Loading…
Stryker Corporation is projected to rise to $333.29 by 2027, a +9% move from its current price of $305.94. SYK is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $301.24 | $305.88 | $310.59 | -0.02% |
| May 30 | $299.28 | $305.82 | $312.51 | -0.04% |
| May 31 | $297.78 | $305.77 | $313.97 | -0.06% |
| Jun 1 | $296.50 | $305.71 | $315.20 | -0.08% |
| Jun 2 | $295.38 | $305.65 | $316.28 | -0.09% |
| Jun 3 | $294.36 | $305.59 | $317.25 | -0.11% |
| Jun 4 | $293.43 | $305.54 | $318.15 | -0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $293.43 | $305.54 | $318.15 | -0.13% |
| Week 2 | $288.17 | $305.13 | $323.09 | -0.26% |
| Week 3 | $284.11 | $304.73 | $326.84 | -0.40% |
| Week 4 | $280.68 | $304.33 | $329.96 | -0.53% |
| Week 5 | $277.65 | $303.92 | $332.69 | -0.66% |
| Week 6 | $274.90 | $303.52 | $335.13 | -0.79% |
| Week 7 | $272.36 | $303.12 | $337.35 | -0.92% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products.
The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Stryker Corporation (SYK) is a medical technology company. The current price is $316.48 per share and the market capitalization is $121.33B, with a rank of 129 by market cap. The stock sits in a neutral near-term position with a 30-day technical backdrop and a defined range.
A major floor 18.3% below — a decisive break under it would weaken the trend.
The nearest floor, 7.6% below — buyers have tended to step in here.
The nearest ceiling, 12.2% above — a clean break opens room to run.
A major ceiling 26.6% above — clearing it would confirm fresh momentum.
Key SYK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SYK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $314.08 | Sell | $311.30 | Sell |
| MA 10 | $311.57 | Sell | $310.25 | Sell |
| MA 20 | $303.80 | Buy | $310.87 | Sell |
| MA 50 | $322.24 | Sell | $322.23 | Sell |
| MA 100 | $343.39 | Sell | $336.12 | Sell |
| MA 200 | $357.22 | Sell | $349.49 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.41 | Neutral |
| Stoch RSI (14) | 65.52 | Neutral |
| CCI (20) | 13.99 | Neutral |
| Williams %R (14) | -39.96 | Info |
| MACD (12,26,9) | 2.56 | Buy |
| ROC (12) | 7.17 | Buy |
| Bollinger %B (20,2) | 0.55 | Neutral |
| Stochastic %K (14) | 60.04 | Neutral |
| TRIX (15) | -0.27 | Sell |
| Awesome (5,34) | -2.77 | Sell |
| Ultimate (7,14,28) | 50.40 | Neutral |
| Momentum (10) | 11.49 | Buy |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 312.83 | Sell |
| ADX (14) | 20.18 | Sell |
| ATR (14) | 5.01 | Info |
The 30-day picture is NEUTRAL with RSI14 at 50. The 50-day simple moving average is $323.59 and the 200-day simple moving average is $357.89. The stock trades between a support level of $282.58 and a resistance level of $347.24, with a 30-day trading range from $286.08 to $350.11.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $282.58 | $305.94 | $395.22 | 0% | Neutral | |
| $272.28 | $333.29 | $427.05 | +9% | Neutral | |
| $278.59 | $347.24 | $456.55 | +14% | Neutral | |
| $339.43 | $429.49 | $576.43 | +40% | Bullish | |
| $372.49 | $477.59 | $652.34 | +56% | Bullish | |
| $391.14 | $507.57 | $704.08 | +66% | Bullish | |
| $411.90 | $540.50 | $760.30 | +77% | Bullish | |
| $405.34 | $537.44 | $765.69 | +76% | Bullish | |
| $438.31 | $586.90 | $846.06 | +92% | Bullish | |
| $491.90 | $664.86 | $969.02 | +117% | Bullish | |
| $623.75 | $879.17 | $1,342.42 | +187% | Bullish | |
| $1,238.39 | $1,871.73 | $3,062.65 | +512% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $282.58 | $305.94 | $358.49 | +0.00% |
| June 2026 | $261.06 | $304.54 | $362.16 | -0.46% |
| July 2026 | $256.30 | $300.72 | $360.99 | -1.26% |
| August 2026 | $260.38 | $306.87 | $371.06 | +2.05% |
| September 2026 | $263.58 | $311.80 | $379.26 | +1.61% |
| October 2026 | $260.26 | $308.92 | $377.78 | -0.93% |
| November 2026 | $261.54 | $311.37 | $382.57 | +0.79% |
| December 2026 | $268.22 | $320.24 | $395.22 | +2.85% |
Click any year to see its month-by-month SYK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Stryker Corporation's 2026 outlook centres on $305.94, within a $282.58 to $395.22 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, SYK could reach as high as $427.05, with a base case around $333.29 and support toward $272.28 — roughly +9% from $305.94. A consolidation phase looks the most probable path here.
Expect SYK to range from $278.59 to $456.55 through 2028. The $347.24 average target implies a +14% move from current prices. That is up +4% on the projected 2027 average. Price action looks broadly range-bound.
The SYK price prediction for 2029 points to an average of $429.49 (low $339.43, high $576.43) — a potential gain of +40% on today's $305.94. Buyers look set to stay in control over this stretch.
In 2030, SYK is projected to trade between $372.49 and $652.34, averaging $477.59 — a potential gain of +56% from today's $305.94. That is up +11% on the projected 2029 average. Momentum favours further upside here.
Stryker Corporation's 2031 outlook centres on $507.57, within a $391.14 to $704.08 range. That is up +6% on the projected 2030 average. That marks a +66% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, SYK could reach as high as $760.30, with a base case around $540.50 and support toward $411.90 — roughly +77% from $305.94. Momentum favours further upside here.
Expect SYK to range from $405.34 to $765.69 through 2033. The $537.44 average target implies a +76% move from current prices. That is -1% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
The SYK price prediction for 2034 points to an average of $586.90 (low $438.31, high $846.06) — a potential gain of +92% on today's $305.94. Momentum favours further upside here.
In 2035, SYK is projected to trade between $491.90 and $969.02, averaging $664.86 — a potential gain of +117% from today's $305.94. That is up +13% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Stryker Corporation's 2040 outlook centres on $879.17, within a $623.75 to $1,342.42 range. That is up +32% on the projected 2035 average. That marks a +187% change versus current levels. Momentum favours further upside here.
By 2050, SYK could reach as high as $3,062.65, with a base case around $1,871.73 and support toward $1,238.39 — roughly +512% from $305.94. Buyers look set to stay in control over this stretch.
Investing $1,000 in SYK today (≈ 3.268615 SYK) could be worth
$6,117.96
+$5,117.96 (+512%) by 2050 · US Dollar
Based on the average projected SYK price of $1,871.73 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SYKwould be worth at today's price.
$1,000 invested in SYK on May 27, 2025 (≈ 2.60566 SYK) would be worth
$797.18
-$202.82 (-20.3%) today · 0.80× · US Dollar
Based on a SYK entry price of $383.78 vs. today's $305.94.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $321.49 | $951.63 | -4.8% |
| 1 month ago | $329.01 | $929.88 | -7.0% |
| 3 months ago | $386.06 | $792.47 | -20.8% |
| 6 months ago | $371.18 | $824.24 | -17.6% |
| 1 year ago | $383.78 | $797.18 | -20.3% |
| All time (5.0y) ago | $255.79 | $1,196.06 | +19.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SYK forecast.
Our base-case forecast reaches $610.00 around 2035.
Implied market cap at $610.00: $233.85B
The year-by-year forecast shows a clear long-horizon uptrend. In 2026 the average price is $316.48 with a neutral sentiment, rising through 2027 ($348.67) and 2028 ($369.07) to 2029 ($461.17) with bullish sentiment. By 2030 the average price is $511.42 and the ROI is 61.6% with bullish sentiment, followed by 2031 at $546.49 (ROI 72.7%), 2032 at $584.99 (ROI 84.8%), 2033 at $582.10 (ROI 83.9%), 2034 at $642.88 (ROI 103.1%), and 2035 at $733.16 (ROI 131.7%).
The forecast continues higher to 2040 with an average of $977.40 (ROI 208.8%) and bullish sentiment, and culminates in 2050 with an average of $2,098.99 (ROI 563.2%) and bullish sentiment. The maximums rise along the path to 2030 ($698.69), 2040 ($1,492.57), and 2050 ($3,434.78). These figures illustrate a sustained bullish trajectory over the multi-year horizon, though they are estimates and not guarantees of future results.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $511.42 with a minimum of $398.80 and a maximum of $698.69, and a bullish sentiment. The implied ROI for 2030 is 61.6%.
The outlook includes a sequence of rising averages and bullish sentiment from 2029 onward, with 2029 averaging $461.17 and 2030 averaging $511.42, among higher later-year levels. These are estimates, not guarantees.
Yes. The maximum forecasted price reaches $1,492.57 by 2040 and $3,434.78 by 2050, indicating potential for prices above $1,000 in the forecast.
Current price is $316.48 per share. Market capitalization is $121.33B, and the rank is 129.
Sentiment is NEUTRAL with RSI at 50. The 50-day SMA is $323.59 and the 200-day SMA is $357.89. The 30-day range is $286.08 to $350.11, with a support level at $282.58 and a resistance at $347.24.
Stryker Corporation Community Discussion
0Share your Stryker Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.